How US Antitrust Can Be on Target: The Brand-Name Prescription Drug Litigation
International Journal of the Economics of Business - United Kingdom
doi 10.1080/758523206
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 1997
Authors
Publisher
Informa UK Limited